Related Experiment Video
Updated: Dec 11, 2025
14:04
Viral Nanoparticles for In vivo Tumor Imaging
Published on: November 16, 2012
17.6K
Challenges in the development of nanoparticle-based imaging agents: Characterization and biology
Rachael M Crist1, Siva Sai Krishna Dasa1, Christina H Liu2
1Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, USA.
Summary
Nanomedicine imaging agents are underrepresented despite early clinical use. New opportunities arise from advances in personalized medicine and nanoparticle technology for improved diagnostics.
Area of Science:
- Nanomedicine
- Diagnostic Tools
- In Vivo Nanodiagnostics and Imaging
Background:
- Despite early clinical use, nanomedicine imaging agents are underrepresented in current research compared to therapeutics.
- Challenges include synthesis, scale-up, biocompatibility, targeting ligand development, and stringent regulatory approval processes.
Purpose of the Study:
- To provide an overview of current trends in nanomedicine imaging agent characterization and biocompatibility.
- To explore new opportunities and future development horizons for nanomedicine-based imaging agents.
Main Methods:
- Review of current literature on nanomedicine imaging agents.
- Analysis of trends in characterization, biocompatibility, and targeting strategies.
- Discussion of emerging opportunities in personalized medicine and immunotherapy.
Main Results:
- Significant underrepresentation of nanomedicine imaging agents in research and development.
- Identification of key challenges hindering progress in the field.
- Emerging trends suggest renewed opportunities for nanodiagnostics.
Conclusions:
- Advancements in personalized medicine and nanoparticle technology offer promising avenues for nanomedicine imaging agent development.
- Addressing challenges in synthesis, targeting, and regulation is crucial for future progress.
- Further research into characterization and biocompatibility will drive innovation in nanodiagnostics.
